J&J to acquire Firefly Bio for $1 billion
In an effort to increase the number of oncology medications in its portfolio, Johnson & Johnson (J&J) said on Monday...
In an effort to increase the number of oncology medications in its portfolio, Johnson & Johnson (J&J) said on Monday...
Strong demand for Lilly's GLP-1 weight-loss and diabetes medications helped offset declining prices in U.S. and foreign markets. Causing the...
Eli Lilly, a U.S. pharmaceutical corporation, and Kelonia Therapeutics, a privately held biotechnology business. Reached an agreement on Monday to...
Eli Lilly's new GLP-1 medication for weight loss, Foundayo, has received FDA approval. After Novo Nordisk's Wegovy was approved last...
Following an earlier surge in pre-market trading, Moderna shares increased 6.4% to approximately $46.75 shortly after the market started on...
Eli Lilly dropped the cost of Zepbound on Monday after the pharmaceutical giant and Ozempic producer Novo Nordisk reached an...
Following President Donald Trump's announcement of a deal with pharmaceutical companies to lower the cost of two well-known medications in...
OpenAI is considering developing consumer health products, including a personal health assistant powered by generative AI, as the creator of...
Nearly a month after departing from her role as CEO of social media platform X, Linda Yaccarino is set to...
The company announced to Forbes on Thursday that Juul will be granted approval from the Food and Drug Administration (FDA)...